The Kaplan-Meier survival curves showed highly significant differences among the three treatment groups ( Fig 3F ).
← all excerpts
A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors.
1
—
—